How Nanomaterials Are Reshaping Biomedical Technology: A conversation with Eric Keller, Art Coury, and Tarek Fadel

Three leading figures in the world of nanotechnology research, commercialization, and policy were invited by IEEE Pulse to discuss how this rapidly emerging area has been shaping biomedical technology in recent years, as well as its most promising applications in years to come. The panel consists of Eric Keller, CEO of Nano Terra Inc., a company devoted to bridging the gap between laboratory research in nanomaterials and coatings and scalable, marketable products; Art Coury, an organic chemist with decades of experience in research for various companies including several years at Genzyme; and Tarek Fadel, a staff scientist with the National Nanotechnology Coordination Office, a central coordinating body for federal research in nanotechnology.